EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

TDP-43 dysfunction destabilizes glial homeostatic identity in ALS/FTD

Anna E Dale, Rita Sattler

Brain Research · 2027-01 · 1895 · 150618

DOI: 10.1016/j.brainres.2026.150618 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Research, 2027-01. Verfasst von Anna E Dale und 1 weiteren Autor:innen. Beteiligte Einrichtung: Barrow Neurological Institute, Dept. of Translational Neuroscience, Phoenix, AZ, United States; Arizona State University, School of Life Science, Int…. Die Arbeit nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Barrow Neurological Foundation, Target ALS Foundation Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TAR DNA-binding protein 43 (TDP-43) pathology is a defining feature of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Although TDP-43 dysfunction has traditionally been studied through a neuron-centric framework, increasing evidence demonstrates that astrocytes, microglia, and oligodendrocytes are also directly affected and actively contribute to disease progression. In this review, we examine how TDP-43 dysfunction disrupts lineage-specific glial homeostatic programs and promotes distinct pathological state transitions across major glial populations. In astrocytes, TDP-43 dysfunction impairs neurotransmitter regulation, metabolic and neuronal support, RNA homeostasis, and secretory signaling while promoting inflammatory and antiviral-like states. In microglia, altered TDP-43 disrupts inflammatory regulation, phagocytosis, lysosomal function, lipid metabolism, and stage-dependent protective responses. In oligodendrocytes, TDP-43 dysfunction compromises RNA processing, lineage maintenance, lipid metabolism, myelin integrity, and long-term axonal support. Together, these findings suggest that glial TDP-43 dysfunction cannot be reduced to a single generalized form of reactivity but instead reflects the breakdown of distinct cell type-specific identities required to maintain central nervous system homeostasis. A cross-glial framework integrating cell-autonomous dysfunction, non-cell-autonomous signaling, disease stage, and genetic context may therefore provide a more complete understanding of TDP-43 proteinopathy and its contribution to neurodegeneration across the ALS-FTD spectrum.

Schlagwörter

Stichwörter der Autor:innen

Amyotrophic lateral sclerosisAstrocytesFrontotemporal dementiaGliaMicrogliaOligodendrocytesTDP-43

Autor:innen und Institutionen

  • Barrow Neurological Institute, Dept. of Translational Neuroscience, Phoenix, AZ, United States; Arizona State University, School of Life Science, Interdisciplinary Graduate Program in Neuroscience, United States.
  • Barrow Neurological Institute, Dept. of Translational Neuroscience, Phoenix, AZ, United States. Electronic address: rita.sattler@barrowneuro.org.

Förderung

  • Barrow Neurological Foundation
  • Target ALS Foundation Inc

Zitieren

APA

Dale, A. E., & Sattler, R. (2027). TDP-43 dysfunction destabilizes glial homeostatic identity in ALS/FTD. Brain Research, 1895, 150618. https://doi.org/10.1016/j.brainres.2026.150618

Vancouver

Dale AE, Sattler R. TDP-43 dysfunction destabilizes glial homeostatic identity in ALS/FTD. Brain Research. 2027;1895:150618. doi:10.1016/j.brainres.2026.150618

BibTeX
@article{Dale2027,
  author = {Dale, Anna E and Sattler, Rita},
  title = {TDP-43 dysfunction destabilizes glial homeostatic identity in ALS/FTD},
  journal = {Brain Research},
  year = {2027},
  volume = {1895},
  pages = {150618},
  doi = {10.1016/j.brainres.2026.150618}
}
Kostenlos starten →